Neurology

A recent ARTESiA trial analysis suggests apixaban may reduce stroke risk in patients with subclinical atrial fibrillation and a history of stroke

Intranasal oxytocin every third day modestly reduced apathy in frontotemporal dementia patients, offering a potential treatment approach.

Butylphthalide reduces cognitive decline in stroke survivors over 12 months, offering promising neuroprotection for post-stroke care.

Ophthalmic complications linked to semaglutide and tirzepatide raise concerns for diabetic patients on these medications.

Researchers have identified a cortical biomarker signature that accurately predicts individual pain sensitivity, paving the way for personalised pain management.

New research shows propranolol reduces Parkinson’s tremor and motor cortex activity, offering a potential treatment option.

Heavy alcohol consumption, particularly binge drinking, is a significant risk factor for cryptogenic ischaemic stroke in young men.

Hearing loss linked to a 57% higher Parkinson’s risk per 10-decibel decline, suggests new Lancaster University study.